Simon Barry J.'s Form 4 filing
ImmunityBio, Inc.IBRX · filed Jan 21, 2026
- Accession no.
- 0001647994-26-000002
- Filed
- Jan 21, 2026
- Trade date
- Jan 20, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.09M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simon Barry J.CIK 0001647994 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Common Stock | SSaleDisposed | −76,967 | $6.54 | −$503,364.18 | 3,166,604 | Direct | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −75,000 | $7.88F2 | −$591,000 | 3,091,604 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 75,000 shares sold in the price range of $7.87 to $7.8950 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit 24 - Power of Attorney